کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2602485 1133762 2015 10 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Comparative endothelial profiling of doxorubicin and daunorubicin in cultured endothelial cells
ترجمه فارسی عنوان
مقیاس اندوتلیال مقایسه دوکسوروبیسین و داونوروبیسین در سلولهای اندوتلیال کشت شده
کلمات کلیدی
دوکسوروبیسین، داونوروبیسین، سمیت مسمومیت، اندوتلیوم، نمایش محتویات بالا
موضوعات مرتبط
علوم زیستی و بیوفناوری علوم محیط زیست بهداشت، سم شناسی و جهش زایی
چکیده انگلیسی


• We compared endothelial cytotoxicity of doxorubicin and daunorubicin.
• Nuclear accumulation and genotoxicity were evident in nanomolar concentrations.
• Effect was more pronounced for daunorubicin than for doxorubicin.
• DNA damage-triggered response was a primary cause of the endothelial toxicity.
• Reactive oxygen species (ROS) generation seems to be a secondary event.

Although anthracycline antibiotics have been successfully used for nearly half a century in the treatment of various malignancies, their use is limited by their cardiac and vascular toxicities, and the mechanisms of these toxicities are still not entirely clear. Herein, we comprehensively characterized cytotoxic effects of two structurally related anthracyclines, doxorubicin and daunorubicin. In nanomolar concentrations, both drugs induced DNA damage and increased nuclear area that were associated with their accumulation in the nucleus (doxorubicin ⩾50 nM and daunorubicin ⩾25 nM) as evidence by Raman microspectroscopy at 3820–4245 cm−1. At low micromolar concentrations, doxorubicin (⩾5 μM) and daunorubicin (⩾1 μM) increased the generation of reactive oxygen species, decreased intracellular reduced glutathione, induced an alteration in endothelial elasticity and caused a reorganization of the F-actin cytoskeleton. In isolated mouse aortic rings, doxorubicin (⩾50 μM) was less potent than daunorubicin (⩾5 μM) in impairing the endothelium-dependent response.In summary, using a comprehensive endothelial profiling approach, we demonstrated clear-cut differences in the potencies to induce endotheliotoxic responses for two structurally similar chemotherapeutics, at a nuclear, cytosolic and membrane levels. Furthermore, our results suggest that the differences in the endothelial toxicities of doxorubicin and daunorubicin are linked to differences in their nuclear accumulation and the DNA damage-triggered response of the endothelium.

Figure optionsDownload as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Toxicology in Vitro - Volume 29, Issue 3, April 2015, Pages 512–521
نویسندگان
, , , , , , , , , ,